Desvenlafaxine

CAS No. 93413-62-8

Desvenlafaxine ( Desvenlafaxine; DVS 233; MDD-XR )

Catalog No. M16675 CAS No. 93413-62-8

Desvenlafaxine (O-desmethylvenlafaxine) the major active metabolite of venlafaxine, is an antidepressant from the serotonin-norepinephrine reuptake inhibitor (SNRI class).

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 80 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Desvenlafaxine
  • Note
    Research use only, not for human use.
  • Brief Description
    Desvenlafaxine (O-desmethylvenlafaxine) the major active metabolite of venlafaxine, is an antidepressant from the serotonin-norepinephrine reuptake inhibitor (SNRI class).
  • Description
    Desvenlafaxine (O-desmethylvenlafaxine) the major active metabolite of venlafaxine, is an antidepressant from the serotonin-norepinephrine reuptake inhibitor (SNRI class). Desvenlafaxine may be used to treat major depressive disorder and is being studied for use in the management of vasomotor symptoms in postmenopausal women. It is formulated as an extended release tablet. FDA approved in 2008.
  • Synonyms
    Desvenlafaxine; DVS 233; MDD-XR
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    5-HT; Norepinephrine (NE)
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    93413-62-8
  • Formula Weight
    263.38
  • Molecular Formula
    C16H25NO2
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 3 mg/mL (11.39 mM); DMSO: 37 mg/mL (140.48 mM)
  • SMILES
    CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Deecher DC, et al. J Pharmacol Exp Ther. 2006 Aug;318(2):657-65.
molnova catalog
related products
  • Dapoxetine HCl

    Dapoxetine HCl is a selectivity short-acting serotonin reuptake inhibitor used for the therapy of premature ejaculation.

  • Vidofludimus

    Vidofludimus (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH).

  • WAY 163909

    A highly potent, subtype-selective agonist of 5-HT2C receptor with Ki of 10.5 nM.